Skip to content

Clinical trials

Phase 3 ST Elevation Myocardial Infarction trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: ST Elevation Myocardial Infarction Phase: Phase 3 Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20152
20161
20191
20201
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
RenJi Hospital2
Ge Junbo1
General Hospital of Chinese Armed Police Forces1
Hospital do Coracao1
Suzhou RxD Biopharmaceutical Co., Ltd1
West China Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
ST Elevation Myocardial Infarction9
Non-ST Elevated Myocardial Infarction2
Acute Coronary Syndrome1
Hyperlipidemias1
Ventricular Dysfunction, Left1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.